Carmona-Furusho LK, Ariza-Andraca CR, Iniestra-Flores F, Soto-Hernández G

Language: Spanish
References: 22
Page: 71-77
PDF size: 255.30 Kb.

ABSTRACT

The prevalence of Streptococcus pneumoniae (S. pneumoniae) resistant to penicillin is an increasing problem with variable prevalence across the world. In Mexico, some reports inform prevalence as high as 50 % of the isolations. S. penumoniae is a germ that produces a wide variety of diseases, although the most serious infections are in respiratory tract and meningitis. Most patients with the infection caused by this microorganism have a good response to the treatment. The cases with bad prognosis and those which are eventually lethal are related to host factors and microbiologic characteristics such as resistance to β-lactam antibiotics. The aim of this paper is to inform on three cases of fulminant meningitis due to S. pneumoniae resistant to penicillin, which presented neurolo-gical focalization, acute loss of consciousness, coma, and death within the first week, in spite of treatment with cephalosporin of third and fourth generation. In all these cases, S. pneumoniae was isolated from cerebrospinal fluid. The presence of similar cases should alert the clinician to consider an early diagnosis of penicillin resistant meningitis in order to establish an appropriate antibiotic therapy, and consequently, modify the prognosis of the patients.

REFERENCES

1. Koedel U, Scheld W, Pfister H. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002;2:721-736.

2. 2. Tay J, Gutiérrez M, Rodríguez M. Microbiología y parasitología médicas. Segunda edición. México: Méndez Editores; 1995,

3. 3. Kragsbjerg P, Kallman J, Olcen P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994;26: 659-666.

4. 4. Viciana M, García-López V, Mariscal A, Sánchez-Bernal A, Clavijo E, Martín E, et al. Aspectos micro-biológicos y clinicoepidemiológicos de los aislados de Streptococcus pneumoniae durante dos años. Enferm Infec Microbiol Clin 2004;22:13-17.

5. 5. Van de Beek D, de Gans J, Spanjaard L. Clinical features and prognostic factors in adults with bac-terial meningitis. N Engl J Med 2004;351:1849-1859.

6. 6. Kastenbauer S, Pfister HW. Pneumococcal menin-gitis in adults: spectrum of complications and prog-nostic factors in a serie of 87 cases. Brain 2003; 126:1015-1025.

7. 7. Chen-Hsien L, Chi-Ren H, Wen-Neng C, et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimi-crobial therapy, and prognostic factors. Clin Neur Neurosurg 2002;104:353-358.

8. 8. Dowson CG, Coffey TJ, Spratt BG. Origin and molecular epidemiology of penicillin-binding protein-mediated resistance to (beta)-lactam antibiotics. Trends Microbiol 1994;2:361-366.

9. 9. Bonafede M, Rice LB. Emerging antibiotic resis-tance. J Lab Clin Med 1997;130:558-566.

10. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-480.

11. Rossi F. Resistencia bacteriana en infecciones res-piratorias en América Latina. XI Congreso Pana-mericano de Infectología, 2003.

12. Butler J, Breiman D, Breiman R. Epidemiology of emerging pneumococcal drug resistence: impli-cations for treatment and prevention. Vaccine 1998;18:1693-1697.

13. Jacobs MR. Drug-Resistant Streptococcus pneumo-niae: rational antibiotic choices. Am J Med 1999;106 (5A):19S-25S.

14. Haddad P, Repka T, Weisdorf D. Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature. Am J Med 2002;113:152-155.

15. Jones R, Wilson W. Epidemiology, laboratory detection and therapy of penicillin-resistant Streptococcal infection. Diagn Microbiol Infect Dis 1998;31:453-459.

16. Markiewicz Z, Tomasz A. Variation in penicillin-binding proteins of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol 1989;27:405-410.

17. Dowson CG, Hutchison A, Brannigan JA, et al. Horizontal transfer of penicillin-binding genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989;86:8842-8846.

18. Harwell JI, Brown RB. The drug-resistant Pneu-mococcus: clinical relevance, therapy, and prevention. Chest 2000;117:530-541.

19. Collignon P, Bell J. Streptococcus pneumoniae how common is penicillin resistance in Australia? Aust N Z J Med 1992;22:473-476.

20. Koornhof H, Wasas A, Lugman K. Antimicrobial resistance in Streptococcus pneumoniae a South African perspective. Clin Infect Dis 1992:15:84-94.

21. Cheng-Hsien L, Wen-Neng C, Hsuen-Ven C. Streptococcal meningitis in adults: therapeutic outcomes and prognostic factors. Clin Neurol Neurosurg 2001;103:137-142.

22. Aronin S. Current pharmacotherapy of pneumo-coccal meningitis. Expert Opin Pharmacother 2002; 3:121-129.